WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling Cascade

Background and purpose: Angiogenesis and lymphangiogenesis are major routes for metastatic spread of tumor cells. It thus represent the rational targets for therapeutic intervention of cancer. Recently, we showed that a novel aliphatic hydroxamate-based compound, WMJ-S-001, exhibits anti-angiogenic,...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shiu-Wen, Yang, Hung-Yu, Huang, Wei-Jan, Chen, Wei-Chuan, Yu, Meng-Chieh, Wang, Shih-Wei, Hsu, Ya-Fen, Hsu, Ming-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851263/
https://www.ncbi.nlm.nih.gov/pubmed/31781495
http://dx.doi.org/10.3389/fonc.2019.01188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851263/
https://www.ncbi.nlm.nih.gov/pubmed/31781495
http://dx.doi.org/10.3389/fonc.2019.01188

Ejemplares similares